A 'telomere-associated secretory phenotype' cooperates with BCR-ABL to drive malignant proliferation of leukemic cells.
about
Pathogenesis of Myeloproliferative Neoplasms: Role and Mechanisms of Chronic InflammationClonal competition in BcrAbl-driven leukemia: how transplantations can accelerate clonal conversion.Combined Population Dynamics and Entropy Modelling Supports Patient Stratification in Chronic Myeloid LeukemiaThe role of telomeres and telomerase in hematologic malignancies and hematopoietic stem cell transplantationClinical and prognostic implications of Roundabout 4 (robo4) in adult patients with acute myeloid leukemia.Telomeric repeat-containing RNA (TERRA) constitutes a nucleoprotein component of extracellular inflammatory exosomes.The Fanconi anemia pathway controls oncogenic response in hematopoietic stem and progenitor cells by regulating PRMT5-mediated p53 arginine methylation.The Hepatocyte Growth Factor (HGF)/Met Axis: A Neglected Target in the Treatment of Chronic Myeloproliferative Neoplasms?Reconstructing the in vivo dynamics of hematopoietic stem cells from telomere length distributionsCytoplasmic RAP1 mediates cisplatin resistance of non-small cell lung cancer.Regulation of normal and leukemic stem cells through cytokine signaling and the microenvironment.The crosstalk of telomere dysfunction and inflammation through cell-free TERRA containing exosomes.TGF-α and IL-6 plasma levels selectively identify CML patients who fail to achieve an early molecular response or progress in the first year of therapy.
P2860
Q26779960-5D81B2FC-B89F-420E-848E-D9E3E3519683Q33908547-A7F2AC96-C6E7-42CE-8DC9-643FA88B7A39Q34521001-B3264759-34AA-4F82-9559-E983D645CA9AQ34544862-A15C429D-F595-4515-965D-38682D5A48C8Q35203340-96E99B50-5941-4F9C-B609-1DD66A444A76Q36306037-B2581B9C-4DD5-420E-8245-DAF85525DA44Q37644979-A67EF8DB-5049-434B-BC14-6411CD668E39Q38239580-8846CAD3-44EC-41C1-AB8A-03FDF9BDB80DQ38273280-56D0E754-8C8D-44B4-AC1F-EFF879241160Q38703087-42BB262E-8611-4314-8989-327CA3A38D7FQ39125504-1AA301EB-E966-4017-A778-4FDBD72867E7Q41458958-B849DBC2-5A97-46D9-9D57-88CF4E50B13EQ53206022-727C5092-5275-4119-8A8E-CBBDA86BE8D7
P2860
A 'telomere-associated secretory phenotype' cooperates with BCR-ABL to drive malignant proliferation of leukemic cells.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
A 'telomere-associated secreto ...... oliferation of leukemic cells.
@en
A 'telomere-associated secreto ...... oliferation of leukemic cells.
@nl
type
label
A 'telomere-associated secreto ...... oliferation of leukemic cells.
@en
A 'telomere-associated secreto ...... oliferation of leukemic cells.
@nl
prefLabel
A 'telomere-associated secreto ...... oliferation of leukemic cells.
@en
A 'telomere-associated secreto ...... oliferation of leukemic cells.
@nl
P2093
P2860
P50
P356
P1433
P1476
A 'telomere-associated secreto ...... oliferation of leukemic cells.
@en
P2093
C Bokemeyer
D Steinemann
M Preukschas
N Pällmann
S Balabanov
T H Brümmendorf
P2860
P2888
P304
P356
10.1038/LEU.2014.95
P577
2014-03-07T00:00:00Z